Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Nov 17, 2023

BUY
$118.38 - $210.04 $97,189 - $172,442
821 Added 31.55%
3,423 $615 Million
Q3 2022

Nov 17, 2023

BUY
$118.07 - $194.18 $307,218 - $505,256
2,602 New
2,602 $308 Million
Q2 2022

Nov 17, 2023

BUY
$117.13 - $176.59 $408,666 - $616,122
3,489 New
3,489 $498 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track National Wealth Management Group, LLC Portfolio

Follow National Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on National Wealth Management Group, LLC with notifications on news.